2nd Quarter - Report

BIOMET, INC. for BIOMET, INC.

Firm
Client
Income
—
Expenses
$150,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

PL 111-148 Medical device excise tax; Physician-owned distributorships (PODs); H.R. 436 Protect Medical Innovation Act; FDA 510(k) reform proposal; Medical Device User Fee and Modernization Act (MDUFMA); S.17-Medical Device Access and Innovation Act; H.R. 1700 - Medicare Patient Empowerment Act; H.R. 1249 - Leahy-Smith America Invents Act

LobbyistCovered position, as disclosed
WILLIAM C KOLTER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1249 (112th), H.R. 1700 (112th), H.R. 436 (112th), S. 17 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.